Solution Structure of the Variable-Type Domain of the Receptor for Advanced Glycation End Products: New Insight into AGE−RAGE Interaction,

Citations Over TimeTop 10% of 2008 papers

Abstract

Diabetes is defined by chronic hyperglycemia due to deficiency in insulin action. It has been found that the amount of advanced glycation end products (AGE) from the Maillard reaction between proteins and sugar molecules increases in blood of diabetic patients and furthermore that AGE binding to their cell surface receptor (RAGE) triggers both macrovascular and microvascular impairments to cause diabetic complications. Due to the clinical significance of the vascular complications, RAGE is currently a focus as an attractive target for drug discovery of candidates which interfere with AGE-RAGE binding to prevent the subsequent intracellular signaling related to pathogenical effects. Here, we determined the three-dimensional structure of the recombinant AGE-binding domain by using multidimensional heteronuclear NMR spectroscopy and showed that the domain assumes a structure similar to those of other immunoglobulin V-type domains. The site-directed mutagenesis studies identified the basic amino acids which play a key role in the AGE binding activities. Our results obtained from this study provide new insight into AGE-RAGE interaction.

Related Papers

• → Advanced Glycation End Product Recognition by the Receptor for AGEs(2011)212 cited
• → Role of Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Cancer Risk(2014)68 cited
• [AGEs and RAGE - advanced glycation end-products and their receptor in questions and answers].(2014)
• → ADVANCED GLYCATION END PRODUCTS AND THEIR RECEPTORS IN CARDIOVASCULAR DISEASES(2019)4 cited
• Advanced Glycation End Products and Its Receptor System and Diabetic Nephropathy(2009)